Skip to main content
. Author manuscript; available in PMC: 2014 Jan 9.
Published in final edited form as: Am Heart J. 2012 Mar;163(3):10.1016/j.ahj.2011.11.022. doi: 10.1016/j.ahj.2011.11.022

Table I.

Patient characteristics and location at time of non-invasive cardiac stress testing, by test type

All
(N=80,676)
Nuclear
Stress MPI
(N=43,700)
Stress
ECHO
(N=16,879)
ETT
(N=20,009)
P-value
Age (mean, interquartile range) 51.5 (46, 57) 52.1 (47, 57) 50.8 (45, 56) 50.7 (45, 56) <.001
Female (%) 53 54 57 46 <.001
Diabetes 9.9 12.0 7.0 7.9 <.001
Hypertension 38.9 43.3 34.5 33.2 <.001
Hyperlipidemia 38.1 40.7 34.1 36.0 <.001
Cerebrovascular Disease 2.4 3.0 2.1 1.6 <001
Peripheral Vascular Disease 1.9 2.2 1.2 1.5 <.001
Chronic Pulmonary Disease 7.4 8.1 6.4 6.7 <.001
Hospital Referral Region* (%) (% of Total) (% of Stress Tests in Referral Region) <.001
  Atlanta (2,647) 3 57 9 34
  Charlotte (914) 1 49 34 17
  Columbus (1,814) 2 64 19 17
  Dallas (4,037) 5 32 47 21
  Denver (1,138) 1 50 10 40
  East Long Island (1,591) 2 65 10 25
  Ft. Lauderdale (1,164) 1 79 11 10
  Ft. Worth (1,684) 2 38 39 23
  Houston (5,320) 7 61 3 36
  Kansas City (1,419) 2 38 51 11
  Los Angeles (962) 1 21 31 48
  Manhattan (1,375) 2 48 19 33
  Miami (1,340) 2 87 7 6
  Milwaukee (1,339) 2 54 24 21
  Nashville (893) 1 65 6 29
  Orlando (1,987) 2 73 3 23
  Phoenix (1,437) 2 50 14 36
  Raleigh (942) 1 53 39 8
  St. Louis (2,812) 4 55 33 12
  Tucson (993) 1 17 24 59
  ALL OTHERS (44,744) 56 55 21 24

MPI = myocardial perfusion imaging; ECHO = echocardiography; ETT = exercise treadmill testing.

*

Data unavailable for 124 patients.

May not sum to 100 due to rounding.